The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models
Article in Biomedicine & Pharmacotherapy (March 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (March 2024)
Preprint in Research Square (January 2024)
Article in Marmara Medical Journal (January 2024)